News Headlines

NitricBio Selects Clinipace Worldwide to Manage Multiple Clinical Trials
14 January 2010
Clinipace will manage and deploy multiple studies in support of medical applications of topical nitric oxide gas.

Altea and KAI Enter into a Preclinical and Clinical Development Agreement
14 January 2010
Agreement aims at the delivery of certain KAI compounds using Altea’s transdermal delivery technology.

Gene Mutations Reveal Potential new Targets for Treating a Type of Non-Hodgkin's Lymphoma
12 January 2010
Findings provide insight into a mechanism that cancer cells may use to survive.

FDA Approves ACTEMRA® for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
11 January 2010
IL-6 receptor-inhibiting monoclonal antibody approved based on largest clinical development program in rheumatoid arthritis to date.

TetraLogic Initiates Phase 1 Clinical Trial of TL32711 in Patients with Lymphoma
11 January 2010
The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors.

Tekmira Pharmaceuticals Completes ApoB SNALP Phase 1 Clinical Trial
11 January 2010
ApoB SNALP is designed to reduce the production of apolipoprotein B.

TB Alliance and BioFocus Sign Compound Management Agreement
11 January 2010
Under the three year compound management agreement BioFocus will manage TB Alliance’s chemical library collection.

Seaside Therapeutics and Vanderbilt University Enter Collaborative Research Agreement
08 January 2010
Collaborations focuses on discovery of novel therapeutics to treat disorders of brain development.